AIHA during pregnancy, rapid immune tolerance induction in severe hemophilia A, and aging changes control of HSC proliferation
AIHA during pregnancy, rapid immune tolerance induction in severe hemophilia A, and aging changes control of HSC proliferation
In this week’s episode we will review treatment and outcomes for patients with autoimmune hemolytic anemia during pregna... Read more
20 Apr 2023
•
17mins
Review Series on Classical Myeloproliferative Neoplasms
Review Series on Classical Myeloproliferative Neoplasms
In this episode Associate Editor, Dr. Mario Cazzola discusses the review series on Classical Myeloproliferative Neoplasm... Read more
20 Apr 2023
•
22mins
Similar Podcasts
The Hematologist
Blood Advances Talks
NEJM This Week
NEJM Interviews
JAMA Clinical Reviews
JAMA Editors' Summary
The BSH Guidelines Official Podcast
Plenary Session
Hematopoiesis: An ASH Trainee Council Production
Annals On Call Podcast
The Curious Clinicians
Core IM | Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
Cardionerds: A Cardiology Podcast
The Clinical Problem Solvers
Factor H variants in paroxysmal nocturnal hemoglobinuria, the role of factor XII in SCD-related thrombosis, and clinical features of therapy-related NPM1-mutated AML
Factor H variants in paroxysmal nocturnal hemoglobinuria, the role of factor XII in SCD-related thrombosis, and clinical features of therapy-related NPM1-mutated AML
In this week’s episode, we’ll learn how rare germline genetic variants in complement factor H (CFH) affect the course of... Read more
14 Apr 2023
•
22mins
Lenalidomide and genetic profiling in myeloma, T-cell immunotherapy upregulates AML cell MHC-class II, and young fecal microbiota rejuvenate HSCs
Lenalidomide and genetic profiling in myeloma, T-cell immunotherapy upregulates AML cell MHC-class II, and young fecal microbiota rejuvenate HSCs
In this week’s episode we will review optimizing the value of post-transplant lenalidomide maintenance in multiple myelo... Read more
6 Apr 2023
•
16mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
HLA-E-restricted immune response in EBV infection, the role of NRX-0492 in CLL, and NSAIDs for bone marrow failure in Ghosal Hematodiaphyseal Dysplasia
HLA-E-restricted immune response in EBV infection, the role of NRX-0492 in CLL, and NSAIDs for bone marrow failure in Ghosal Hematodiaphyseal Dysplasia
In this week’s episode we’ll learn how HLA-E-restricted immune responses help control Epstein-Barr virus infection, disc... Read more
30 Mar 2023
•
23mins
Review Series on Germ Line Predisposition to Hematologic Malignancy
Review Series on Germ Line Predisposition to Hematologic Malignancy
In this bonus episode Associate Editor, Dr. Mario Cazzola discusses the review series on Germline predisposition to hema... Read more
30 Mar 2023
•
33mins
Anti-malaria benefit of hydroxyurea in SCA, IL-22 in the treatment in lower GI acute GVHD, and FLT3-ITD changes depend on context in AML
Anti-malaria benefit of hydroxyurea in SCA, IL-22 in the treatment in lower GI acute GVHD, and FLT3-ITD changes depend on context in AML
In this week’s episode we will review a study in sub-Saharan Africa where treatment of sickle cell anemia with hydroxyur... Read more
23 Mar 2023
•
18mins
Single-cell genotyping of MDS/CMML clonal output, VTE risk in diffuse glioma, and Del(1p32) is an adverse prognostic factor in myeloma
Single-cell genotyping of MDS/CMML clonal output, VTE risk in diffuse glioma, and Del(1p32) is an adverse prognostic factor in myeloma
In this week’s episode we’ll discuss how azacytidine therapy influences the contributions of mutated HSC clones to hemat... Read more
16 Mar 2023
•
20mins
RUNX1 isoform imbalance drives ML-DS, VWF-binding RNA aptamer for hemophilia A treatment, and EZH1/2 inhibitor valemetostat in relapsed/refractory ATL
RUNX1 isoform imbalance drives ML-DS, VWF-binding RNA aptamer for hemophilia A treatment, and EZH1/2 inhibitor valemetostat in relapsed/refractory ATL
In this week’s episode we will review an imbalance among RUNX1 isoforms is key to the pathogenesis of trisomy 21-associa... Read more
9 Mar 2023
•
17mins
Phase 3 trial of leniolisib in activated PI3Kδ syndrome, dabrafenib plus trametinib in relapsed/refractory hairy cell leukemia, and TγδLGL leukemia as a more symptomatic subset of leukemia
Phase 3 trial of leniolisib in activated PI3Kδ syndrome, dabrafenib plus trametinib in relapsed/refractory hairy cell leukemia, and TγδLGL leukemia as a more symptomatic subset of leukemia
In this week’s episode, we’ll discuss the findings from a phase 3 trial of PI3Kδ inhibitor leniolisib in activated PI3Kd... Read more
2 Mar 2023
•
21mins
